methadone has been researched along with Infant, Small for Gestational Age in 12 studies
Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
Infant, Small for Gestational Age: An infant having a birth weight lower than expected for its gestational age.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In early pregnancy, 10,704 pregnant persons were exposed to buprenorphine and 4387 to methadone." | 8.12 | Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy. ( Bateman, BT; Connery, HS; Davis, JM; Gray, KJ; Hernández-Díaz, S; Huybrechts, KF; Jones, HE; Lester, B; Mogun, H; Straub, L; Suarez, EA; Terplan, M, 2022) |
| "To examine the association between retention in methadone treatment during pregnancy and key neonatal outcomes." | 7.74 | Methadone in pregnancy: treatment retention and neonatal outcomes. ( Burns, L; Lim, K; Mattick, RP; Wallace, C, 2007) |
| "Weight loss was less in small for gestational age compared to appropriately grown infants (p<0." | 5.38 | Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding. ( Campbell, N; Dryden, C; Mactier, H; Young, D, 2012) |
| " In early pregnancy, 10,704 pregnant persons were exposed to buprenorphine and 4387 to methadone." | 4.12 | Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy. ( Bateman, BT; Connery, HS; Davis, JM; Gray, KJ; Hernández-Díaz, S; Huybrechts, KF; Jones, HE; Lester, B; Mogun, H; Straub, L; Suarez, EA; Terplan, M, 2022) |
| "Two national cohorts of women receiving opioid maintenance treatment during pregnancy showed small but not statistically significant differences in neonatal outcomes in favour of buprenorphine compared with methadone." | 3.88 | Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. ( Engeland, A; Gabrhelík, R; Handal, M; Lund, IO; Mravčík, V; Nechanská, B; Skurtveit, S, 2018) |
| " Methadone use in pregnancy has been associated with adverse perinatal outcomes and neonatal abstinence syndrome (NAS)." | 3.78 | Methadone and perinatal outcomes: a prospective cohort study. ( Carmody, D; Clarke, T; Cleary, BJ; Eogan, M; Fahey, T; Gallagher, PJ; Gleeson, J; McDermott, C; Murphy, DJ; O'Connell, MP; O'Sullivan, A; White, MJ, 2012) |
| "To examine the association between retention in methadone treatment during pregnancy and key neonatal outcomes." | 3.74 | Methadone in pregnancy: treatment retention and neonatal outcomes. ( Burns, L; Lim, K; Mattick, RP; Wallace, C, 2007) |
| " Mean birthweight of infants born to mothers abusing heroin during the pregnancy was 2,490 gm, an effect primarily of intrauterine growth retardation." | 3.65 | Differential effects of maternal heroin and methadone use on birthweight. ( Albin, S; Berle, B; Eidelman, AI; Gartner, LM; Kandall, SR; Lowinson, J, 1976) |
| "Weight loss was less in small for gestational age compared to appropriately grown infants (p<0." | 1.38 | Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding. ( Campbell, N; Dryden, C; Mactier, H; Young, D, 2012) |
| "85% of the newborns had withdrawal symptoms and 12% had convulsions the severity of which was not correlated with the type of drug abuse." | 1.27 | Investigation of 89 children born by drug-dependent mothers. I. Neonatal course. ( Andersen, GE; Buckley, W; Friis-Hansen, B; Olofsson, M, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Suarez, EA | 3 |
| Huybrechts, KF | 3 |
| Straub, L | 3 |
| Hernández-Díaz, S | 3 |
| Jones, HE | 3 |
| Connery, HS | 3 |
| Davis, JM | 3 |
| Gray, KJ | 3 |
| Lester, B | 3 |
| Terplan, M | 3 |
| Mogun, H | 3 |
| Bateman, BT | 3 |
| Nechanská, B | 1 |
| Mravčík, V | 1 |
| Skurtveit, S | 1 |
| Lund, IO | 1 |
| Gabrhelík, R | 1 |
| Engeland, A | 1 |
| Handal, M | 1 |
| Dryden, C | 1 |
| Young, D | 1 |
| Campbell, N | 1 |
| Mactier, H | 1 |
| Cleary, BJ | 1 |
| Eogan, M | 1 |
| O'Connell, MP | 1 |
| Fahey, T | 1 |
| Gallagher, PJ | 1 |
| Clarke, T | 1 |
| White, MJ | 1 |
| McDermott, C | 1 |
| O'Sullivan, A | 1 |
| Carmody, D | 1 |
| Gleeson, J | 1 |
| Murphy, DJ | 1 |
| Burns, L | 1 |
| Mattick, RP | 1 |
| Lim, K | 1 |
| Wallace, C | 1 |
| Olofsson, M | 1 |
| Buckley, W | 1 |
| Andersen, GE | 1 |
| Friis-Hansen, B | 1 |
| Hogerzeil, HV | 1 |
| Soepatmi, S | 1 |
| Kreijenbroek, M | 1 |
| Treffers, PE | 1 |
| Dar, H | 1 |
| Schmidt, R | 1 |
| Nitowsky, HM | 1 |
| Oleske, JM | 1 |
| Kandall, SR | 1 |
| Albin, S | 1 |
| Lowinson, J | 1 |
| Berle, B | 1 |
| Eidelman, AI | 1 |
| Gartner, LM | 1 |
| Lam, SK | 1 |
| To, WK | 1 |
| Duthie, SJ | 1 |
| Ma, HK | 1 |
| Ellwood, DA | 1 |
| Sutherland, P | 1 |
| Kent, C | 1 |
| O'Connor, M | 1 |
12 other studies available for methadone and Infant, Small for Gestational Age
| Article | Year |
|---|---|
Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy.
Topics: Buprenorphine; Cesarean Section; Cohort Studies; Female; Humans; Infant; Infant, Low Birth Weight; I | 2022 |
Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy.
Topics: Buprenorphine; Cesarean Section; Cohort Studies; Female; Humans; Infant; Infant, Low Birth Weight; I | 2022 |
Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy.
Topics: Buprenorphine; Cesarean Section; Cohort Studies; Female; Humans; Infant; Infant, Low Birth Weight; I | 2022 |
Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy.
Topics: Buprenorphine; Cesarean Section; Cohort Studies; Female; Humans; Infant; Infant, Low Birth Weight; I | 2022 |
Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
Topics: Abortion, Spontaneous; Adult; Analgesics, Opioid; Apgar Score; Buprenorphine; Czech Republic; Female | 2018 |
Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding.
Topics: Adolescent; Adult; Birth Weight; Bottle Feeding; Breast Feeding; Female; Gestational Age; Humans; In | 2012 |
Methadone and perinatal outcomes: a prospective cohort study.
Topics: Adult; Benzodiazepines; Dose-Response Relationship, Drug; Female; Heroin Dependence; Humans; Infant, | 2012 |
Methadone in pregnancy: treatment retention and neonatal outcomes.
Topics: Adult; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Small for Gestational Age; Methad | 2007 |
Investigation of 89 children born by drug-dependent mothers. I. Neonatal course.
Topics: Adult; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Small | 1983 |
[Pregnancy in heroin addiction; an 11-year survey at the Wilhelmina Gasthuis in Amsterdam].
Topics: Female; Heroin Dependence; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Sma | 1982 |
Palmar crease variants and their clinical significance: a study of newborns at risk.
Topics: Adult; Age Factors; Child; Child, Preschool; Dermatoglyphics; Down Syndrome; Female; Fetus; Hand; Hu | 1977 |
Experiences with 118 infants born to narcotic-using mothers. Does a lowered serum-ionized calcium level contribute to the symptoms of withdrawal?
Topics: Calcium; Female; Follow-Up Studies; Heroin Dependence; Humans; Infant, Low Birth Weight; Infant, New | 1977 |
Differential effects of maternal heroin and methadone use on birthweight.
Topics: Adult; Birth Weight; Dose-Response Relationship, Drug; Ethnicity; Female; Gestational Age; Heroin; H | 1976 |
Narcotic addiction in pregnancy with adverse maternal and perinatal outcome.
Topics: Adult; Female; Fetal Growth Retardation; Heroin Dependence; Hong Kong; Humans; Infant, Low Birth Wei | 1992 |
Maternal narcotic addiction: pregnancy outcome in patients managed by a specialized drug-dependency antenatal clinic.
Topics: Adolescent; Adult; Female; Fetal Death; Health Facilities; Heroin Dependence; Humans; Infant, Newbor | 1987 |